Literature DB >> 1933291

Postmortem cerebral cortex Gs alpha-subunit levels are elevated in bipolar affective disorder.

L T Young1, P P Li, S J Kish, K P Siu, J J Warsh.   

Abstract

We examined the relative abundance of G-protein subunits in postmortem brain obtained from 7 patients with bipolar affective disorder (BAD) compared with 7 age- and sex-matched controls. G-protein subunit immunoreactivities were determined in membranes prepared from postmortem prefrontal cortex using SDS-PAGE and immunoblotting with specific polyclonal antisera against selected G-protein subunits: Gsa, Gi(1&2) alpha, Go alpha and G beta(1&2). Of these G-protein subunits, only Gs alpha immunoreactivity was found to be significantly elevated in frontal (+ 34%), and occipital (+ 80%) cortex (P less than 0.05) in BAD compared with control subjects. Smaller increments (+ 22%) in cerebellar Gs alpha immunoreactivity were also found but were not statistically significant. On the basis that increased Gs alpha immunoreactivity may reflect enhanced functional responsiveness of the receptor-effector units to which this coupling protein is integral, the present findings suggest that disturbances in Gs-mediated signal transduction may be involved in the pathophysiology of BAD.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1933291     DOI: 10.1016/0006-8993(91)90843-k

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

Review 1.  A Role for Phosphodiesterase 11A (PDE11A) in the Formation of Social Memories and the Stabilization of Mood.

Authors:  Michy P Kelly
Journal:  Adv Neurobiol       Date:  2017

2.  Differential effects of the antipsychotics haloperidol and clozapine on G protein measures in mononuclear leukocytes of patients with schizophrenia.

Authors:  S Avissar; G Roitman; G Schreiber
Journal:  Cell Mol Neurobiol       Date:  2001-12       Impact factor: 5.046

Review 3.  Overview of the brain polyamine-stress-response: regulation, development, and modulation by lithium and role in cell survival.

Authors:  Gad M Gilad; Varda H Gilad
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

Review 4.  Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part II: bipolar disorder.

Authors:  Mark J Niciu; Dawn F Ionescu; Daniel C Mathews; Erica M Richards; Carlos A Zarate
Journal:  CNS Spectr       Date:  2013-03-11       Impact factor: 3.790

5.  Adenylate cyclase regulates elongation of mammalian primary cilia.

Authors:  Young Ou; Yibing Ruan; Min Cheng; Joanna J Moser; Jerome B Rattner; Frans A van der Hoorn
Journal:  Exp Cell Res       Date:  2009-07-02       Impact factor: 3.905

6.  Chronic Galphas signaling in the striatum increases anxiety-related behaviors independent of developmental effects.

Authors:  Christopher Favilla; Ted Abel; Michele P Kelly
Journal:  J Neurosci       Date:  2008-12-17       Impact factor: 6.167

7.  Imbalance of the Gs and Gi/o function in post-mortem human brain of depressed patients.

Authors:  H Ozawa; W Gsell; L Frölich; R Zöchling; F Pantucek; H Beckmann; P Riederer
Journal:  J Neural Transm Gen Sect       Date:  1993

8.  Heterotrimeric g proteins: insights into the neurobiology of mood disorders.

Authors:  Javier González-Maeso; J Javier Meana
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

9.  PDE11A regulates social behaviors and is a key mechanism by which social experience sculpts the brain.

Authors:  Shweta Hegde; Hao Ji; David Oliver; Neema S Patel; Nicolas Poupore; Michael Shtutman; Michy P Kelly
Journal:  Neuroscience       Date:  2016-08-17       Impact factor: 3.590

10.  Phosphodiesterases PDE2A and PDE10A both change mRNA expression in the human brain with age, but only PDE2A changes in a region-specific manner with psychiatric disease.

Authors:  Reagan Farmer; Steven D Burbano; Neema S Patel; Angelo Sarmiento; Abigail J Smith; Michy P Kelly
Journal:  Cell Signal       Date:  2020-02-29       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.